Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Direxion Daily S&P Biotech Bull 3X Shares stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LABU.
Open | $47.00 |
High | $47.65 |
52 Wk High | $152.60 |
AUM | 553.99M |
Dividend | $0.51 |
Ex-Div Date | Mar 25, 2025 |
Volume | 774.71K |
Market Cap | $26.59B |
Mgmt Fee | 0.75% |
P/E Ratio | 25.12 |
Prev. Close | $48.19 |
Low | $44.58 |
52 Wk Low | $32.55 |
Shares Out | 10.47M |
Yield | 1.07% |
Div. Freq | Quarterly |
Avg. Volume Daily | 1.97M |
Beta | 3.01 |
Avg. Expense Ratio | 0.93% |
P/B Ratio | 3.94 |
You can purchase shares of Direxion Daily S&P Biotech Bull 3X Shares (ARCA:LABU) through any online brokerage.
There are no as such competitors for Direxion Daily S&P Biotech Bull 3X Shares.
There is no analysis for Direxion Daily S&P Biotech Bull 3X Shares to provide a consensus price target.
The stock price for Direxion Daily S&P Biotech Bull 3X Shares (ARCA: LABU) is $45.3644 last updated April 16, 2025 at 12:41 PM EDT.
A quarterly cash dividend of 0.15 per share of Class A Common Stock. The quarterly cash dividend was payable on July 2, 2024 to stockholders of record on June 25, 2024.
Direxion Daily S&P Biotech Bull 3X Shares does not have any upcoming earnings scheduled.
There is no upcoming split for Direxion Daily S&P Biotech Bull 3X Shares.
Open | $47.00 |
High | $47.65 |
52 Wk High | $152.60 |
AUM | 553.99M |
Dividend | $0.51 |
Ex-Div Date | Mar 25, 2025 |
Volume | 774.71K |
Market Cap | $26.59B |
Mgmt Fee | 0.75% |
P/E Ratio | 25.12 |
Prev. Close | $48.19 |
Low | $44.58 |
52 Wk Low | $32.55 |
Shares Out | 10.47M |
Yield | 1.07% |
Div. Freq | Quarterly |
Avg. Volume Daily | 1.97M |
Beta | 3.01 |
Avg. Expense Ratio | 0.93% |
P/B Ratio | 3.94 |
Sector | Healthcare |
Category | High Performer-High Growth |
Investment Style | Multi Alternative |
Fund Inception | May 28, 2015 |
Managers | Tony Ng Paul Brigandi |
Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |